2016 Top Doctors


Return to Table of Contents

Dr. Robert S. Mannel

Gynecologic Oncology, Stephenson Cancer Center University of Oklahoma Health Sciences Center

Photo by Brent Fuchs.
Photo by Brent Fuchs.

[dropcap]During[/dropcap] medical residency, Dr. Robert S. Mannel was introduced to the gynecologic oncology field and “felt a professional calling to work with these brave women,” he says. Since then, he has worked to not only advance his specialty but assist the medical community in finding new ways to fight cancer.

Today, Dr. Mannel is the Rainbolt Family Endowed Chair in Cancer, the director of the Stephenson Cancer Center and a distinguished professor within the department of obstetrics and gynecology at the University of Oklahoma Health Sciences Center in Oklahoma City.

He shares that in Oklahoma one in two men and one in three women will develop cancer at some point in his or her life, and 35 percent of patients diagnosed with cancer succumbed to their disease in 2015.

“Gynecologic cancers play a major role in these numbers, with endometrial cancer being the fourth most common cancer in women and ovarian cancer being one of the most lethal,” says Dr. Mannel. “Overall, gynecologic cancers account for over 35,000 deaths annually in women and trail only lung, breast and colorectal cancer in mortality. The only way to change these staggering statistics are to invest in research – both laboratory and clinical trials – so we can improve cancer patients’ chances.”

Dr. Mannel has published more than 100 peer review articles on gynecologic cancer and obtained more than $10 million in grant funding for research with the National Cancer Institute (NCI) in the National Clinical Trials Network (NCTN) to advance the science of how to care for patients with cancer. He is also the chair of the gynecologic cancer committee for the NCI/NCTN system, which oversees cooperative group clinical trial research nationally and is a member of the NCI Gynecologic Cancer Steering Committee which sets research direction for gynecologic cancers. – Rebecca Fast